Libman-Sacks Endocarditis with Unusual Large Size Vegetation Involving the Mitral Valve
AbstractAntiphospholipid syndrome (APS) is an autoimmune hypercoagulable disorder characterized by thrombophilia, vascular thrombosis, and recurrent abortions associated with persistent antiphospholipid antibodies. APS may exist in its primary form, or more commonly is found to be associated with variety of rheumatic disorders, such as systemic lupus erythematosus. Cardiac involvement is not an uncommon complication in primary antiphospholipid patients. Libman-Sacks lesions are typically small, sessile, and wart-like, varying in size from 1-4 mm. Here we present an unusual case of a 37 year-old pregnant woman who suffered from heart failure associated with primary antiphospholipid syndrome and Libman-Sacks endocarditis, with large vegetations involving the mitral valve. The patient underwent mitral valve replacement with a mechanical prosthesis.
Bouma W, Klinkenberg TJ, Horst ICC, Wijdh-den Hamer IJ, Erasmus ME, et al. 2010. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothoracic Surg 5:1-13.
Cervera R. 2004. Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 114:501-7.
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, et al. 2002. Antiphospholipid syn-drome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019-27.
Davies JO, Hunt BJ. 2007. Myocardial infarction in young patients without coronary atheroscle-rosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract 61:379-384.
Hoffer E, Itoua M, Radermecker M, Pierard L. 2000. Stenosis of a mechanical mitral prosthetic valve in a patient with systemic lupus erythematosus. Acta Cardiol 55:49-5.
Lee JL, Naguwa SM, Cheema GS, Gershwin ME. 2009. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol 36:126-30.
Long BR, Leya F. 2008. The role of antiphospholipid syndrome in cardiovascular disease. He-matol Oncol Clin North Am 22:79-94.
Moaref AR, Afifi S, Rezaian S, Rezaian GR. 2010. Isolated tricuspid valve Libman-Sacks endo-carditis and valvular stenosis: unusual manifestations of systemic lupus erythematosus. J Am Soc Echocardiogr 23:341.
Nesher G, Ilany J, Rosenmann D, Abraham AS. 1997. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 27:27-35.
Pritzker MR, Ernst JD, Caudill C, Wilson CS, Weaver WF, et al. 1980. Acquired aortic stenosis in systemic lupus erythematosus. Ann Intern Med 93:434-436.
Roldan CA. 2008. Valvular and coronary heart disease in systemic inflammatory diseases: Sys-temic Disorders in heart disease. Heart 94:1089-101.
Roldan CA, Qualls CR, Sopko KS, Sibbitt WL. 2008. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 35:224-229.
Roldan CA, Sibbitt WL Jr, Qualls CR, Jung RE, Greene ER, et al. 2013. Libman-Sacks endo-carditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging 6:973-83.
Tanawuttiwat T, Dia M, Hanif T, Mihailescu M. 2011. Double-Valve Libman-Sacks Endocardi-tis Causing Ventricular Fibrillation Cardiac Arrest. Tex Heart Inst J 38:295-7.
Zhixuan Bai, Jianglong Hou, Wenjun Ren, Yingqiang Guo. 2015. Diagnosis and surgical treat-ment for isolated tricuspid libman-sacks endocarditis: a rare case report and literatures review. Journal of Cardiothoracic Surgery 10:93.
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).